MiMedx Group MDXG Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $418.63M+20.0% | $348.88M+8.5% | $321.48M+20.0% | $267.84M+10.7% | ||
| $73.01M+21.5% | $60.07M+10.0% | $54.63M+13.1% | $48.32M+21.9% | ||
| $345.62M+19.7% | $288.81M+8.2% | $266.84M+21.6% | $219.53M+8.5% | ||
| 82.6%-0.2pp | 82.8%-0.2pp | 83%+1.0pp | 82%-1.7pp | ||
| $15.1M+22.3% | $12.34M-2.5% | $12.66M— | —— | ||
| $266.19M+18.3% | $225.09M+6.6% | $211.13M+1.2% | $208.67M+7.1% | ||
| $63.89M+8.5% | $58.86M+58.6% | $37.11M— | —— | ||
| 15.3%-1.6pp | 16.9%+5.3pp | 11.5%— | —— | ||
| $2.93M— | —— | -$6.46M-28.7% | -$5.02M— | ||
| -$558K+1.2% | -$565K— | —— | -$3K+87.0% | ||
| $66.26M+15.7% | $57.29M+87.0% | $30.63M— | —— | ||
| $17.68M+15.6% | $15.3M+142% | -$36.81M-17,967% | $206K— | ||
| $0.32+14.3% | $0.28-26.3% | $0.38+215% | -$0.33-106% | ||
| $78.77M+21.4% | $64.91M+60.1% | $40.54M— | —— | ||
| 18.8%+0.2pp | 18.6%+6.0pp | 12.6%— | —— | ||
| $63.89M+8.5% | $58.86M+58.6% | $37.11M— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is MiMedx Group's revenue?
- MiMedx Group (MDXG) generated $389.4M in revenue over the trailing twelve months, up 10.5% year over year.
- Is MiMedx Group profitable?
- MiMedx Group reported $30.7M in net income over the trailing twelve months, a 7.9% net margin.
- What are MiMedx Group's profit margins?
- Gross margin is 81.0% and operating margin is 10.2%, with a 7.9% net margin.
- What is MiMedx Group's earnings per share?
- MiMedx Group's diluted EPS over the trailing twelve months is $0.20.
- Where does MiMedx Group's income statement data come from?
- Every line is extracted from MiMedx Group's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
